Eczema is a condition that causes patches of skin to become dry, inflamed, and irritated,” explains Joel Schlessinger, MD, a board-certified dermatologist in Omaha, NE and RealSelf contributor. “It’s ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...

Mounjaro is a brand name for tirzepatide. As an injectable in the thigh, stomach or arm, tirzepatide reduces appetite and improves how the body breaks down sugar and fat. However the 'Mounjaro ...

Eli Lilly (NYSE:LLY) reported strong Q4 2024 results on Thursday, surpassing Wall Street estimates, driven by a more than twofold increase in sales of its weight loss and diabetes drugs Mounjaro ...

First we had Oatzempic, the viral drink heralded for its magical weight loss powers. And now TikTokers are raving about a ...

Eli Lilly's Q4 revenue rose 45% YoY to $13.53B, driven by Mounjaro and Zepbound. Adjusted EPS hit $5.32, beating the $4.94 consensus. 2025 guidance projects $58B-$61B in sales, with a 32% growth ...

On Today with Claire Byrne, Maura Fay reports on the rollout of Mounjaro in Ireland and speaks to medical experts about issues surrounding access to this medication. Listen back above. The most ...

GLP-1 drugs Mounjaro and Zepbound drive a big revenue increase for the drugmaker Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound ...

Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a big revenue increase Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound ...

New rules mean people seeking weight loss jabs will need to verify their body mass index by video consultation ... injections of drugs like Wegovy or Mounjaro after just completing a patient ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout ... adults who have a body mass index (BMI) of at least 35 kg/m2 and at least one weight-related health problem.